Manatū Hauora | Ministry of Health
Today, consultation openednorth_east on a proposal by Pharmac and the Ministry of Health (Medsafe) to improve access to stimulant medicines used in the treatment of attention deficit hyperactivity disorder (ADHD).
The proposal suggests broadening the range of people who can initiate treatment of stimulant medicines which, over time, would lead to more doctors and nurse practitioners being able to diagnose and treat ADHD.
Group Manager of Medsafe, Chris James, says “the intent of the proposal is to increase access to ADHD medicines for people who need them. The proposal follows feedback from the sector that these changes may help reduce wait times and costs for people at a time when our workforce is under pressure.”